1. Home
  2. ZSTK vs COCP Comparison

ZSTK vs COCP Comparison

Compare ZSTK & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZeroStack Corp. Common Stock

ZSTK

ZeroStack Corp. Common Stock

N/A

Current Price

$4.84

Market Cap

19.0M

Sector

Health Care

ML Signal

N/A

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.24

Market Cap

21.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZSTK
COCP
Founded
2019
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.0M
21.6M
IPO Year
2023
2011

Fundamental Metrics

Financial Performance
Metric
ZSTK
COCP
Price
$4.84
$1.24
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
1.3M
52.9K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.65
EPS
N/A
N/A
Revenue
$35,676,000.00
$12,712,091.00
Revenue This Year
$15.73
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.32
$0.76
52 Week High
$12.40
$2.03

Technical Indicators

Market Signals
Indicator
ZSTK
COCP
Relative Strength Index (RSI) 58.54 64.59
Support Level $4.76 $1.17
Resistance Level $5.39 $1.59
Average True Range (ATR) 0.98 0.07
MACD -0.13 0.01
Stochastic Oscillator 32.52 68.47

Price Performance

Historical Comparison
ZSTK
COCP

About ZSTK ZeroStack Corp. Common Stock

ZeroStack Corp is an AI focused asset management company. The company also operates a world-wide Commercial and wholesale business through its wholly owned subsidiary. ZeroStack is focused on providing exposure to decentralized AI through a concentrated digital asset approach structured to generate yield and fee-based income from staking validators, compute power technology companies, and complementary businesses within the ecosystem and across the wider AI landscape. The other segment commercial and wholesale (Phatebo and TruHC), which sell pharmaceutical products and mix of products across multiple categories including food and beverage, cannabis accessories and technology, personal care and wellness.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

Share on Social Networks: